New cardiac rehabilitation treatment for ischemic heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of a novel cardiac rehabilitation therapy that includes early respiratory rehabilitation, exercise therapy, and extracorporeal shock wave treatment for patients with ischemic heart disease. It compares this new approach to traditional cardiac rehabilitation methods, focusing on patient compliance and outcomes. Participants will receive either the new therapy combined with standard drug treatment or traditional rehabilitation methods over a treatment period of 1 to 3 months, followed by a 6-month evaluation of their heart health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged between 18 and 85 years old
* Female subjects no pregnancy
* The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)
* The need for cardiac rehabilitation treatment

Exclusion Criteria:

* acute respiratory distress syndrome (ARDS);
* acute episode of COPD;
* uncontrolled pulmonary infection;
* acute heart failure; acute pulmonary embolism;
* acute myocarditis/pericarditis;
* severe arrhythmia (degree II or III atrioventricular block, atrial flutter, or atrial fibrillation);
* sternotomy, rib fracture, thoracic deformity, or other neurological diseases that may affect respiratory muscles

Where it's running

• Department of Cardiology, Shanghai Tenth People's Hospital
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: liujing liu, MD, PhD
• Email: liuweijing98@sina.com
• Phone: +86 18917684041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease

  This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.

  Recruiting Lithuanian University of Health Sciences · Kulautuva · NCT07927829

• Tailored digital support to cut sedentary time in long-term cardiac rehab

  In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.

  Recruiting University of Lisbon · Lisbon, Lisbon District · NCT07910812

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• QFR-guided virtual stenting to optimize PCI before the procedure

  We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07635407

• eCardiacRehab: a home-based, patient-centered cardiac rehab program

  This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.

  Recruiting Haukeland University Hospital · Bergen · NCT07590635

• LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions

  This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.

  Recruiting at 10 sites Fundación EPIC · Cabueñes and 9 other locations · NCT07399002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.